KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio: 2017-2020

Historic Debt Ratio for Xenon Pharmaceuticals (XENE) over the last 2 years, with Mar 2020 value amounting to 0.07.

  • Xenon Pharmaceuticals' Debt Ratio fell 49.96% to 0.07 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.07, marking a year-over-year decrease of 49.96%. This contributed to the annual value of 0.11 for FY2019, which is N/A change from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Debt Ratio of 0.07 as of Q1 2020, which was down 37.14% from 0.11 recorded in Q4 2019.
  • Over the past 5 years, Xenon Pharmaceuticals' Debt Ratio peaked at 0.18 during Q1 2018, and registered a low of 0.07 during Q1 2020.
  • In the last 3 years, Xenon Pharmaceuticals' Debt Ratio had a median value of 0.14 in 2019 and averaged 0.13.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Debt Ratio soared by 36.47% in 2019 and then slumped by 49.96% in 2020.
  • Quarterly analysis of 4 years shows Xenon Pharmaceuticals' Debt Ratio stood at 0.15 in 2017, then reached 0.11 in 2018, then skyrocketed by 36.47% to 0.11 in 2019, then plummeted by 49.96% to 0.07 in 2020.
  • Its Debt Ratio stands at 0.07 for Q1 2020, versus 0.11 for Q4 2019 and 0.16 for Q3 2019.